Ep
Non verificato

Epsilogen

Di cosa scriviamo

BiotecnologiaFarmaceuticaOncologiaSaluteScienza
07/10/2025
Scienza
Biotecnologia
Sanità
Salute
Farmaceutica
Oncologia
Mercato del lavoro
Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer
1.00
07/04/2025
Mercato azionario
Industria
Scienza
Biotecnologia
Salute
Farmaceutica
Oncologia
Epsilogen Announces Acquisition of TigaTx, Inc. to Create World’s Leading Pan-Isotype Cancer Antibody Company
1.00
03/12/2024
Industria
Scienza
Farmaceutica
Oncologia
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
Epsilogen Announces Initiation of Phase Ib Trial of MOv18 IgE
1.00
09/09/2024
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Medicina - Varie
Epsilogen Completes £12.5 Million Series B Financing Expansion
1.00
08/07/2024
Industria
Biotecnologia
Salute
Farmaceutica
Oncologia
Scienza
Vetrine/Shopping
Medicina - Varie
Epsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
1.00
01/05/2024
Mercato del lavoro
Legge/Diritto
Fisco/Tributi
Medicina - Varie
Scienza
Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0